WallStreetZenWallStreetZen

NASDAQ: AARD
Aardvark Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Aardvark Therapeutics earnings were -$20.6M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest AARD earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$8.8M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AARD reported annual earnings of -$20.6M, with 185.6% growth.

AARD earnings history

Current Revenue
$0.0
Current Earnings
-$20.6M
Current Profit Margin
0%

AARD Return on Equity

Insufficient data to display

AARD undefined

Current Company
-46.8%
Current Industry
-0.4%
AARD is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AARD announces earnings.

AARD undefined

Current Company
-28.37%
Current Industry
5.9%

AARD vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AARD-$20.34M-$20.59MN/A-$5.15
DMAC-$24.30M-$24.44MN/A-$0.60
KOD-$149.50M-$176.21MN/A-$3.35
ACIU-$54.02M-$56.57MN/A-$0.57
SLN-$43.87M-$45.31MN/A-$0.99
View Top Biotech Stocks

Aardvark Therapeutics Earnings Reports & History FAQ

What were Aardvark Therapeutics's earnings last quarter?

Aardvark Therapeutics (NASDAQ: AARD) reported Q4 2024 earnings per share (EPS) of -$2.18, up 319.23% year over year. Total AARD earnings for the quarter were -$8.78 million. In the same quarter last year, Aardvark Therapeutics's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Aardvark Therapeutics stock.

Is Aardvark Therapeutics profitable or losing money?

As of the last Aardvark Therapeutics earnings report, Aardvark Therapeutics is currently losing money. Aardvark Therapeutics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$20.59 million, a 185.63% increase year over year.

What was AARD's earnings growth in the past year?

As of Aardvark Therapeutics's earnings date in Q2 2025, Aardvark Therapeutics's earnings has grown year over year. AARD earnings in the past year totalled -$20.59 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.